{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:23:25Z","timestamp":1761513805327,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.clbc.2020.03.005","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T21:11:39Z","timestamp":1584652299000},"page":"300-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating Family History Links between Breast Cancer and Prostate Cancer Among PLCO Trial Participants"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5117-2502","authenticated-orcid":false,"given":"Omar","family":"Abdel-Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2020.03.005_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.breast.2017.06.003","article-title":"Trends and predictions to 2020 in breast cancer mortality in Europe","volume":"36","author":"Carioli","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2020.03.005_bib2","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1016\/j.clgc.2019.05.015","article-title":"Prostate cancer incidence and mortality in relationship to family history of prostate cancer; findings from the PLCO trial","volume":"17","author":"Abdel-Rahman","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clbc.2020.03.005_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-020-02329-3","article-title":"Subtype-specific risk factors for postmenopausal breast cancer: findings from the PLCO trial","author":"Abdel-Rahman","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.clbc.2020.03.005_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1097-0142(19930701)72:1<114::AID-CNCR2820720122>3.0.CO;2-0","article-title":"Familial breast cancer risks. Effects of prostate and other cancers","volume":"72","author":"Anderson","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2020.03.005_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/(SICI)1097-0215(20000615)86:6<883::AID-IJC20>3.0.CO;2-F","article-title":"Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives","volume":"86","author":"Valeri","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2020.03.005_bib6","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/cncr.29075","article-title":"Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women\u2019s Health Initiative Study","volume":"121","author":"Beebe-Dimmer","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2020.03.005_bib7","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1158\/1078-0432.CCR-18-0370","article-title":"Family history of breast or prostate cancer and prostate cancer risk","volume":"24","author":"Barber","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2020.03.005_bib8","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2020.03.005_bib9","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1001\/jama.2011.1591","article-title":"Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial","volume":"306","author":"Oken","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2020.03.005_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S2468-1253(18)30358-3","article-title":"Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial","volume":"4","author":"Miller","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clbc.2020.03.005_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12885-018-4098-y","article-title":"Male BRCA mutation carriers: clinical characteristics and cancer spectrum","volume":"18","author":"Ibrahim","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2020.03.005_bib12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1399-0004.2006.00673.x","article-title":"Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and\/or ovarian cancer families of French Canadian descent","volume":"70","author":"Oros","year":"2006","journal-title":"Clin Genet"},{"key":"10.1016\/j.clbc.2020.03.005_bib13","first-page":"1345","article-title":"Second primary cancers in men with prostate cancer: an increased risk of male breast cancer","volume":"169","author":"Thellenberg","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clbc.2020.03.005_bib14","doi-asserted-by":"crossref","first-page":"f3829","DOI":"10.1136\/bmj.f3829","article-title":"Familial breast cancer: summary of updated NICE guidance","volume":"346","author":"Evans","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2020.03.005_bib15","doi-asserted-by":"crossref","first-page":"212540","DOI":"10.7573\/dic.212540","article-title":"Advances in the use of PARP inhibitor therapy for breast cancer","volume":"7","author":"McCann","year":"2018","journal-title":"Drugs Context"},{"key":"10.1016\/j.clbc.2020.03.005_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11864-017-0480-2","article-title":"PARP inhibitors in prostate cancer","volume":"18","author":"Ramakrishnan Geethakumari","year":"2017","journal-title":"Curr Treat Options Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820920300616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820920300616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:19:41Z","timestamp":1761513581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820920300616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1526820920300616"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2020.03.005","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating Family History Links between Breast Cancer and Prostate Cancer Among PLCO Trial Participants","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2020.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}